JLABS vet Calcagno becomes CBO of Vir

Infectious disease company Vir Biotechnology Inc. (NASDAQ:VIR) hired Jeff Calcagno as EVP and CBO. Calcagno, a 12-year veteran of Johnson & Johnson (NYSE:JNJ), was most recently head, J&J Innovation – JLABS, Bay Area.

Therini Bio Inc. named Frank Lee as executive chairperson. Lee was president and CEO of Forma Therapeutics Inc., which Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) acquired in 2022 for $1.1 billion. Therini is developing fibrin therapies for inflammatory neurodegenerative and retinal diseases, and initiated first-in-human dosing in a Phase I study of lead asset THN391, a fibrin-targeting therapeutic candidate for Alzheimer’s disease...